Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Cancer. 2011 Nov 30;11:499. doi: 10.1186/1471-2407-11-499.

Improved blood tests for cancer screening: general or specific?

Author information

1
Translational Oncology Research Centre, Queen Alexandra Hospital, Southwick Hill, Portsmouth, PO6 3LY, UK. ian.cree@porthosp.nhs.uk

Abstract

Diagnosis of cancer at an early stage leads to improved survival. However, most current blood tests detect single biomarkers that are of limited suitability for screening, and existing screening programmes look only for cancers of one particular type. A new approach is needed. Recent developments suggest the possibility of blood-based screening for multiple tumour types. It may be feasible to develop a high-sensitivity general screen for cancer using multiple proteins and nucleic acids present in the blood of cancer patients, based on the biological characteristics of cancer. Positive samples in the general screen would be submitted automatically for secondary screening using tests to help define the likelihood of cancer and provide some indication of its type. Only those at high risk would be referred for further clinical assessment to permit early treatment and mitigate potential overdiagnosis. While the assays required for each step exist, they have not been used in this way. Recent experience of screening for breast, cervical and ovarian cancers suggest that there is likely to be widespread acceptance of such a strategy.

PMID:
22128772
PMCID:
PMC3285105
DOI:
10.1186/1471-2407-11-499
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center